Research Group
Dissecting mechanisms of respiratory disease and defining biomarkers to create therapies.
Our research on airways disease has a distinct life-course perspective of development and progression. Researchers in the area of allergy investigate genetic and environmental factors and how epigenetic mechanisms play a role in modifying the risk of allergic disease in order to determine how the process may be reversed.
Our work is recognised internationally for its translational approach, including epidemiology and genetics, cell and molecular biology, biochemistry, pathology, therapeutic target discovery and validation, lung imaging, early proof of pharmacological efficacy and phase I-III clinical trials.
